Der Kaninchen Polyklonal anti-LIN7A Antikörper wird verwendet zum Nachweis von LIN7A in Proben von Human, Maus und Ratte. Er wurde validiert für WB und ELISA.
LIN7A
Reaktivität: Human
WB
Wirt: Maus
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
LIN7A
(Lin-7 Homolog A (LIN7A))
Andere Bezeichnung
LIN7A
Hintergrund
Protein lin-7 homolog A, Lin-7A, hLin-7, Mammalian lin-seven protein 1, MALS-1, Tax interaction protein 3, TIP-33, Vertebrate lin-7 homolog 1, Veli-1LIN7A (Lin-7 Homolog A, Crumbs Cell Polarity Complex Component) is a Protein Coding gene. Diseases associated with LIN7A include Pulmonary Aspergilloma and Chronic Cervicitis. Among its related pathways are Protein-protein interactions at synapses and Neurotransmitter Release Cycle. The protein encoded by LIN7A is involved in generating and maintaining the asymmetric distribution of channels and receptors at the cell membrane. The encoded protein also is required for the localization of some specific channels and can be part of a protein complex that couples synaptic vesicle exocytosis to cell adhesion in the brain.